Debrisoquin (hydroiodide)
Debrisoquin (hydroiodide) is the hydrochloride form of Debrisoquin. Debrisoquin is a TMPRSS2 inhibitors that inhibits SARS-CoV-2 entry into human lung cell line by a TMPRSS2-depedent manner. Debrisoquin can be used for antiviral research[1].
Product Specifications
CAS Number
1052540-65-4
Product Name Alternative
Debrisoquine (hydroiodide) ; Isocaramidine (hydroiodide) ; Ro 5-3307/1 (hydroiodide)
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
SARS-CoV; Ser/Thr Protease
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/debrisoquin-hydroiodide.html
Concentration
10mM
Purity
99.84
Solubility
DMSO : 175 mg/mL (ultrasonic) |H2O : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N=C(N1CC2=C(CC1)C=CC=C2)N.I
Molecular Formula
C10H14IN3
Molecular Weight
303.15
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SLC35E3-set siRNA/shRNA/RNAi Lentivector (Human)